PM2.5 Exposure and 10-Year Cardiovascular Disease Risk in Fujian, China

From May 2021 to January 2022, a cross-sectional study of 9,539 residents in Fujian Province, China, explored the relationship between fine particulate matter (PM2.5) exposure and atherosclerotic cardiovascular disease (ASCVD) risk. The dataset, authored by Ying Han and last updated in April 2026, includes mediation analyses of blood and urinary biomarkers like glycosylated hemoglobin and uric acid. PM2.5 exposure was estimated using the China High Air Pollutants (CHAP) dataset with 1 km spatial resolution.

Use Cases

• Modeling the association between PM2.5 exposure and 10-year cardiovascular disease risk based on the China-PAR model mentioned in the description
• Investigating effect modification by age, smoking, alcohol consumption, and hypertension based on the stratified analyses described
• Analyzing the mediating role of blood glucose and uric acid biomarkers in the PM2.5-ASCVD relationship as indicated in the conclusion

Strengths

• Includes data from 9,539 individuals, providing a substantial sample size for analysis
• PM2.5 exposure estimates are derived from the CHAP dataset with a 1 km spatial resolution
• Study design incorporates mediation analysis for specific blood and urinary biomarkers

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data is limited to a single province in China over a 9-month period, which may affect generalizability

Provenance

Source

figshare

Collection Method

Cross-sectional study among residents, with PM2.5 exposure estimated from the CHAP dataset.

Time Range

May 2021 to January 2022

Freshness

Last updated 2026-04-10 05:29:21; freshness should be verified

Geography

Fujian Province, China